Summary
Boston Scientific Corporation (BSX) filed its 2010 Form 10-K on February 16, 2011, indicating its status as a large accelerated filer. The company reported an aggregate market value of common stock held by non-affiliates of approximately $8.6 billion as of June 30, 2010, with 1,523,368,979 shares outstanding as of January 31, 2011. This filing provides a comprehensive overview of the company's business, risk factors, financial condition, and results of operations for the fiscal year ended December 30, 2010. Investors should pay close attention to the Management's Discussion and Analysis (MD&A) for insights into the company's performance drivers, strategic initiatives, and future outlook. While detailed financial statements and operational data are not included in the provided excerpt, the structure of the 10-K indicates that investors can find critical information regarding BSX's market position, financial health, and potential challenges. The inclusion of "Risk Factors" and "Legal Proceedings" sections suggests that investors should be aware of potential headwinds and litigation risks that could impact the company's performance and valuation. The reference to incorporated documents, such as the proxy statement, also suggests that further information on corporate governance and executive compensation will be available.
Financial Highlights
49 data points| Revenue | $7.81B |
| Cost of Revenue | $2.60B |
| Gross Profit | $5.21B |
| SG&A Expenses | $2.58B |
| Operating Expenses | $5.86B |
| Operating Income | -$656.00M |
| Interest Expense | $393.00M |
| Net Income | -$1.06B |
| EPS (Basic) | $-0.70 |
| EPS (Diluted) | $-0.70 |
| Shares Outstanding (Basic) | 1.52B |
| Shares Outstanding (Diluted) | 1.52B |
Key Highlights
- 1Boston Scientific Corporation is classified as a large accelerated filer.
- 2The company's market capitalization for non-affiliates was approximately $8.6 billion as of June 30, 2010.
- 3As of January 31, 2011, BSX had 1,523,368,979 shares of common stock outstanding.
- 4The 10-K covers the fiscal year ending December 30, 2010.
- 5Key sections for investors include Business, Risk Factors, and Management's Discussion and Analysis of Financial Condition and Results of Operations.
- 6Portions of the company's 2011 Proxy Statement are incorporated by reference into Part III, offering insights into corporate governance and executive compensation.